APP Receives Two FDA Approvals for Fludarabine Phosphate.

Extract


APP Receives Two FDA Approvals for Fludarabine Phosphate.

SCHAUMBURG, Ill. -- Abraxis Pharmaceutical Products (APP), the hospital-based business of Abraxis BioScience, Inc. (NASDAQ:ABBI), to...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company